Navidea Biopharmaceuticals PE Ratio 2010-2023 | NAVB
Current and historical p/e ratio for Navidea Biopharmaceuticals (NAVB) from 2010 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Navidea Biopharmaceuticals PE ratio as of May 16, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Navidea Biopharmaceuticals PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2023-10-05 | 0.08 | 0.00 | |
| 2023-09-30 | 0.09 | $-0.06 | 0.00 |
| 2023-06-30 | 0.09 | $-0.29 | 0.00 |
| 2023-03-31 | 0.26 | $-0.51 | 0.00 |
| 2022-12-31 | 0.21 | $-0.56 | 0.00 |
| 2022-09-30 | 0.25 | $-0.57 | 0.00 |
| 2022-06-30 | 0.72 | $-0.40 | 0.00 |
| 2022-03-31 | 0.79 | $-0.39 | 0.00 |
| 2021-12-31 | 1.00 | $-0.40 | 0.00 |
| 2021-09-30 | 1.75 | $-0.39 | 0.00 |
| 2021-06-30 | 1.83 | $-0.46 | 0.00 |
| 2021-03-31 | 2.02 | $-0.54 | 0.00 |
| 2020-12-31 | 2.15 | $-0.67 | 0.00 |
| 2019-12-31 | 1.26 | $-0.80 | 0.00 |
| 2019-09-30 | 0.69 | $-1.05 | 0.00 |
| 2019-06-30 | 0.63 | $-1.01 | 0.00 |
| 2019-03-31 | 2.76 | $-1.17 | 0.00 |
| 2018-12-31 | 2.05 | $-1.33 | 0.00 |
| 2020-09-30 | 2.70 | $-1.73 | 0.00 |
| 2018-09-30 | 4.61 | $-2.20 | 0.00 |
| 2018-06-30 | 4.57 | $-2.00 | 0.00 |
| 2018-03-31 | 7.20 | $-2.20 | 0.00 |
| 2017-12-31 | 7.17 | $9.00 | 0.80 |
| 2017-09-30 | 8.30 | $9.20 | 0.90 |
| 2017-06-30 | 10.20 | $9.40 | 1.09 |
| 2017-03-31 | 11.53 | $9.20 | 1.25 |
| 2016-12-31 | 12.75 | $-1.31 | 0.00 |
| 2016-09-30 | 18.31 | $-1.31 | 0.00 |
| 2016-06-30 | 10.61 | $-1.71 | 0.00 |
| 2020-06-30 | 3.94 | $-1.91 | 0.00 |
| 2016-03-31 | 18.89 | $-3.00 | 0.00 |
| 2015-12-31 | 26.60 | $-3.60 | 0.00 |
| 2015-09-30 | 45.60 | $-3.33 | 0.00 |
| 2015-06-30 | 32.20 | $-3.33 | 0.00 |
| 2015-03-31 | 31.80 | $-3.13 | 0.00 |
| 2020-03-31 | 0.76 | $-3.53 | 0.00 |
| 2014-12-31 | 37.80 | $-5.00 | 0.00 |
| 2014-09-30 | 26.40 | $-6.00 | 0.00 |
| 2014-06-30 | 29.60 | $-6.80 | 0.00 |
| 2014-03-31 | 37.00 | $-7.20 | 0.00 |
| 2013-12-31 | 41.40 | $-6.80 | 0.00 |
| 2013-09-30 | 53.00 | $-6.20 | 0.00 |
| 2013-06-30 | 53.40 | $-6.20 | 0.00 |
| 2013-03-31 | 54.20 | $-5.60 | 0.00 |
| 2012-12-31 | 56.60 | $-5.80 | 0.00 |
| 2012-09-30 | 55.00 | $-6.00 | 0.00 |
| 2012-06-30 | 74.40 | $0.00 | 0.00 |
| 2012-03-31 | 65.60 | $0.80 | 82.00 |
| 2011-12-31 | 52.40 | $1.20 | 43.67 |
| 2011-09-30 | 59.20 | $2.20 | 26.91 |
| 2011-06-30 | 66.40 | $-2.60 | 0.00 |
| 2011-03-31 | 79.00 | $-15.00 | 0.00 |
| 2010-12-31 | 41.20 | $-14.60 | 0.00 |
| 2010-09-30 | 37.60 | $-14.00 | 0.00 |
| 2010-06-30 | 36.00 | $-20.20 | 0.00 |
| 2010-03-31 | 32.80 | $-11.60 | 0.00 |
| 2009-12-31 | 24.40 | $-10.80 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.003B | $0.000B |
| Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents for diseases such as cancer and Alzheimer. The Company's radiopharmaceutical development programs include: Lymphoseek(R), AZD4694 and RIGScan(TM). Navidea Biopharmaceuticals, Inc., formerly Neoprobe Corporation, is headquartered in Dublin, Ohio. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $227.942B | 27.62 |
| Intuitive Surgical (ISRG) | United States | $140.614B | 84.71 |
| Edwards Lifesciences (EW) | United States | $54.300B | 35.34 |
| DexCom (DXCM) | United States | $52.458B | 79.46 |
| IDEXX Laboratories (IDXX) | United States | $44.675B | 52.37 |
| Alcon (ALC) | Switzerland | $43.915B | 31.47 |
| IQVIA Holdings (IQV) | United States | $42.817B | 24.84 |
| STERIS (STE) | Ireland | $22.799B | 26.64 |
| Waters (WAT) | United States | $21.385B | 31.43 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.521B | 0.00 |
| Hologic (HOLX) | United States | $17.492B | 19.57 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.139B | 15.34 |
| ShockWave Medical (SWAV) | United States | $12.422B | 77.31 |
| Sysmex ADR (SSMXY) | Japan | $10.769B | 33.77 |
| Teleflex (TFX) | United States | $10.295B | 16.02 |
| Globus Medical (GMED) | United States | $8.657B | 25.38 |
| Penumbra (PEN) | United States | $7.812B | 88.78 |
| Masimo (MASI) | United States | $6.403B | 36.88 |
| Glaukos (GKOS) | United States | $5.561B | 0.00 |
| TransMedics (TMDX) | United States | $4.444B | 421.66 |
| Integer Holdings (ITGR) | United States | $3.987B | 24.09 |
| PROCEPT BioRobotics (PRCT) | United States | $3.504B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $3.405B | 20.22 |
| Tandem Diabetes Care (TNDM) | United States | $3.031B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.942B | 20.18 |
| Inari Medical (NARI) | United States | $2.692B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.478B | 20.95 |
| RxSight (RXST) | United States | $2.303B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $2.166B | 9.45 |
| Veracyte (VCYT) | United States | $1.789B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.599B | 0.00 |
| Artivion (AORT) | United States | $0.980B | 94.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.937B | 18.23 |
| OPKO Health (OPK) | United States | $0.906B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.886B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.758B | 0.00 |
| Paragon 28 (FNA) | United States | $0.661B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.651B | 22.09 |
| SiBone (SIBN) | United States | $0.623B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.596B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.567B | 0.00 |
| IRadimed (IRMD) | United States | $0.540B | 30.25 |
| Pulse Biosciences (PLSE) | United States | $0.436B | 0.00 |
| Nevro (NVRO) | United States | $0.410B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.349B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.325B | 11.11 |
| Sight Sciences (SGHT) | United States | $0.289B | 0.00 |
| AxoGen (AXGN) | United States | $0.261B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.257B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.256B | 0.00 |
| NeuroPace (NPCE) | United States | $0.246B | 0.00 |
| 908 Devices (MASS) | United States | $0.237B | 0.00 |
| Inogen (INGN) | United States | $0.211B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.202B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.193B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.186B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.175B | 0.00 |
| CVRx (CVRX) | United States | $0.174B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.167B | 8.48 |
| Accuray (ARAY) | United States | $0.166B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.108B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.106B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.105B | 22.14 |
| Spectral Diagnostics (EDTXF) | Canada | $0.097B | 0.00 |
| Neuronetics (STIM) | United States | $0.076B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.067B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.066B | 0.00 |
| Hyperfine (HYPR) | United States | $0.061B | 0.00 |
| Envoy Medical (COCH) | United States | $0.059B | 0.00 |
| InspireMD (NSPR) | Israel | $0.057B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.057B | 0.00 |
| DarioHealth (DRIO) | United States | $0.056B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.049B | 0.00 |
| LENSAR (LNSR) | United States | $0.047B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.047B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.046B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.044B | 0.00 |
| Precision Optics (POCI) | United States | $0.040B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.036B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.035B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.033B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.031B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.029B | 0.00 |
| Spectral AI (MDAI) | United States | $0.028B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.026B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.020B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.019B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.018B | 0.00 |
| PAVmed (PAVM) | United States | $0.018B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.017B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.004B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |